4891 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
TMS Co., Ltd. engages in the research and development of pharmaceutical products and medical devices. It focuses on a family of compounds called Stachybotrys microspora triprenyl phenol (SMTPs). The company was founded by Keiji Hasumi on February 17, 2005 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
4891 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company